Kabalin J N
Urology Section, Veterans Affairs Medical Center, Palo Alto, California.
J Urol. 1994 Nov;152(5 Pt 1):1463-6. doi: 10.1016/s0022-5347(17)32446-1.
Periurethral injection of polytetrafluoroethylene (Teflon) paste was performed to treat moderate to severe stress urinary incontinence following prostatectomy. A total of 20 procedures was performed in 13 men, of whom 8 had previously undergone radical prostatectomy for prostate cancer and 5 had undergone transurethral electrocautery resection of the prostate for bladder outlet obstruction due to benign prostatic hyperplasia. All patients had significant stress urinary incontinence requiring a minimum of 2 pads wet daily. Between 16 and 20 cc polytetrafluoroethylene paste were injected initially transurethrally into the periurethral tissues in the region of the external sphincter. Of the 13 patients 7 underwent a second injection procedure with an additional 12 to 23 cc paste. Three men (23%) experienced a noticeable improvement in continence status, including 1 of 5 patients after transurethral electrocautery resection and 2 of 8 after radical prostatectomy. However, none of these men became completely dry or was able to eliminate completely the use of pads. Of the 13 patients 10 (77%) experienced no detectable improvement in continence status. Seven patients have now successfully undergone implantation of an artificial urinary sphincter without complication. With a minimum followup of 11 months in all patients and a maximum followup of 3 years, none has experienced any clinically detectable long-term side effects related to the polytetrafluoroethylene injection or evidence of particulate migration.
采用尿道周围注射聚四氟乙烯(特氟龙)糊剂治疗前列腺切除术后中至重度压力性尿失禁。13名男性共接受了20次该治疗,其中8人此前因前列腺癌接受了根治性前列腺切除术,5人因良性前列腺增生导致膀胱出口梗阻接受了经尿道前列腺电切术。所有患者均有明显的压力性尿失禁,每天至少需要2片尿垫。最初经尿道向尿道外括约肌区域的尿道周围组织注射16至20立方厘米的聚四氟乙烯糊剂。13名患者中有7人接受了第二次注射,额外注射了12至23立方厘米的糊剂。3名男性(23%)的控尿状况有明显改善,包括经尿道前列腺电切术后5名患者中的1名以及根治性前列腺切除术后8名患者中的2名。然而,这些男性中没有一人完全干爽或能够完全停止使用尿垫。13名患者中有10人(77%)的控尿状况没有明显改善。7名患者现已成功植入人工尿道括约肌,无并发症发生。所有患者的最短随访时间为11个月,最长随访时间为3年,没有一人出现与聚四氟乙烯注射相关的任何临床可检测到的长期副作用,也没有微粒迁移的证据。